Quoin Pharmaceuticals (QNRX) Retained Earnings (2017 - 2026)
Quoin Pharmaceuticals (QNRX) posted Retained Earnings of $84.7 million for Q1 2026, up 0.77% sequentially from $84.1 million in Q4 2025, and up 30.56% YoY from $64.9 million in Q1 2025.
Quoin Pharmaceuticals (QNRX) Retained Earnings (2017 - 2026) Analysis & Trends
Quoin Pharmaceuticals has reported Retained Earnings for 10 years, with the latest figure at $84.7 million in Q1 2026.
- Quarterly Retained Earnings rose 30.56% year-over-year to $84.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $84.7 million (up 30.56% YoY) and the FY2025 annual result came in at $84.1 million, up 30.64% from the prior year.
- Retained Earnings advanced to $84.7 million in Q1 2026 per QNRX's latest filing, from $84.1 million in the prior quarter.
- Over five years, Retained Earnings peaked at $84.7 million in Q1 2026 and troughed at -$66.6 million in Q3 2025.
- A 5-year average of $46.8 million and a median of $56.1 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2025: Retained Earnings surged 267.27% in 2023, then plunged 214.28% in 2025.
- Over 5 years, Retained Earnings stood at $47.9 million in 2022, then increased by 8.38% to $51.9 million in 2023, then gained by 24.11% to $64.4 million in 2024, then soared by 30.64% to $84.1 million in 2025, then rose by 0.77% to $84.7 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $84.7 million, $84.1 million, and -$66.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Quoin Pharmaceuticals | 531,643.73 | 531,643.73 | - | 85.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.74 Mn |
| Dec 31, 2025 | 84.09 Mn |
| Sep 30, 2025 | -66.62 Mn |
| Jun 30, 2025 | 65.23 Mn |
| Mar 31, 2025 | 64.90 Mn |
| Dec 31, 2024 | 64.37 Mn |
| Sep 30, 2024 | 58.30 Mn |
| Jun 30, 2024 | 57.98 Mn |
| Mar 31, 2024 | 57.66 Mn |
| Dec 31, 2023 | 51.87 Mn |
| Sep 30, 2023 | 54.50 Mn |
| Jun 30, 2023 | 54.23 Mn |
| Mar 31, 2023 | 53.97 Mn |
| Dec 31, 2022 | 47.86 Mn |
| Sep 30, 2022 | 47.62 Mn |
| Jun 30, 2022 | -32.42 Mn |
| Dec 31, 2021 | 31.66 Mn |
| Dec 31, 2020 | -6.61 Mn |
| Jun 30, 2020 | 36.60 Mn |
| Jun 30, 2019 | 30.37 Mn |